Updated guidelines of reporting pharmacoeconomics and health technology assessment results from 2022 ISPOR (CHEERS 2022)
In 2022, ISPOR released an updated checklist on economic evaluation of health care, since the latter several years have passed, the circumstances have changed, and science has progressed that it demanded fresh relevant changes. To support decision-making in accordance with the principles of evidence...
Main Authors: | M. A. Truuts, A. A. Kurilev, A. S. Kolbin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2022-11-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/624 |
Similar Items
-
Nothing to Cheer About: Endorsing Imaginary Economic Evaluations and Value Claims with CHEERS 22 [version 1; peer review: 2 approved]
by: Paul Langley
Published: (2022-02-01) -
ISPOR 2013: what's new and what's old?
by: Orietta Zaniolo, et al.
Published: (2013-12-01) -
Treating rheumatoid arthritis to target: Revision of the 2014 International Expert Group Recommendations
by: N. T. Vatutin, et al.
Published: (2016-09-01) -
ICER, ISPOR AND QALYs: A Tale of Imaginary Worlds
by: Paul Langley
Published: (2019-11-01) -
Health technology assessment of colorectal cancer chemotherapy with afl ibercept
by: A. S. Kolbin, et al.
Published: (2018-05-01)